Investigating the effects of metformin and automated insulin delivery on kidney and heart health in youth with Type 1 Diabetes
Official title: MANATEE-T1D: Metformin ANd AutomaTEd insulin delivery system Effects on renal vascular resistance, insulin sensitivity, and cardiometabolic function in youth with Type 1 Diabetes
Funded at Seattle Children's Hospital · NIH-11210200 · Data updated 2026-11-12
This study is looking at whether taking metformin along with an automated insulin delivery system can help improve kidney and heart health in young people aged 12-21 with Type 1 Diabetes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Seattle Children's Hospital NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | September 1, 2021 |
| Project end | July 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $182,477 |
| NIH project number | 7K23HL159292-05 |
| Project ID | NIH-11210200 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are youth aged 12-21 years with Type 1 Diabetes who are using automated insulin delivery systems.
✕Less likely to help
Patients who are not using automated insulin delivery systems or are outside the age range may not benefit from this research.
What this research studies
This research explores how metformin, a medication commonly used for diabetes, combined with automated insulin delivery systems, can improve kidney function and heart health in young people with Type 1 Diabetes. The study involves a randomized trial where participants aged 12-21 will receive either metformin or a placebo while using an automated insulin delivery system. Researchers will measure changes in insulin sensitivity and renal vascular resistance to understand the potential benefits of this combined approach. The goal is to find effective strategies to reduce the risk of kidney and cardiovascular diseases in youth with diabetes.
Why it matters
Potential benefit: If successful, this research could lead to improved kidney and heart health outcomes for young people with Type 1 Diabetes.
How similar studies have gone: Previous research has shown that metformin can improve insulin sensitivity in youth with Type 1 Diabetes, but the combination with automated insulin delivery systems is a novel approach.
Where this research is happening
-
Seattle Children's Hospital
Seattle, United States Active
Researchers
- Principal investigator: Tommerdahl, Kalie L — Seattle Children's Hospital
- Study coordinator: Tommerdahl, Kalie L
Related research
Other NIH-funded projects on the same topics.
-
Technological and Educational Approaches to Restore Hypoglycemia Awareness in Type 1 Diabetes
A two-arm study in adults with type 1 diabetes tests whether high-tech glucose control plus education or targeted training can help people regain awareness of low blood sugar.
-
Techniques for restoring awareness of low blood sugar in adults with type 1 diabetes
A randomized trial compares different approaches to help adults with type 1 diabetes recognize when their blood sugar is dipping so they can act quickly.
-
Treating impaired hypoglycemia awareness in type 1 diabetes with targeted education and technology
This study tests two treatment approaches to help adults with type 1 diabetes who often don’t realize their blood sugar is getting too low, using a mix of technology and education in two large groups.
-
Helping people with type 1 diabetes regain awareness of dangerous lows
A UK study tests two different approaches to help adults with type 1 diabetes recognize and respond to low blood sugar by comparing a high-tech insulin system with targeted education.
-
How the pancreas environment affects insulin-producing cells in type 1 diabetes
Researchers are studying how the surrounding tissue of the pancreas and its proteins influence insulin-producing cells in people with type 1 diabetes.
-
Understanding how hypoglycemia awareness changes in adults with type 1 diabetes and how automated insulin delivery and exercise might help restore it
This study will look at adults with type 1 diabetes to see how their awareness of low blood sugar evolves over time and whether automated insulin delivery and high-intensity exercise can help restore that awareness.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.